BIPSX : PROFUNDS BIOTECH ULTRA SECTOR SVC

1
 
 
 
 

ZACKS RANK: 1 - STRONG BUY

Ticker: BIPSX
Manager: Team Managed
Manager Since: NA
NAV (04/21/2014): 38.53
Objective: Equity - Sector Health
Peer: HL LG
Net Assets ($mil): 25.30
Inception: 06/19/2000
BIPSX : Description

The fund was incepted in June 2000 and is managed by ProFund Advisors. The fund seeks daily investment results that correspond to 150%, before fees and expenses, of the performance of the Dow Jones U.S. Biotechnology Index. The fund primarily invests in biotechnology companies. It concentrates investments in a particular industry or group of industries to approximately the same extent the Index is concentrated. The fund may invest in equity caps, collars and floors, swaps, American Depositary Receipts and options on securities and securities indices. Dividends and capital gains are distributed annually.

BIPSX : Composition - 04/14
Stocks 64.56%
Foreign Stocks 0.00%
Cash 0.00%
Bonds 0.00%
Foreign Bonds 0.00%
Preferred 0.00%
Convertible 0.00%
Other 35.44%
Foreign Hedged 0.00%
Composition Horizontal Bar Chart
BIPSX : Style Analysis - 04/14
Large Growth NA
Large Value NA
Small Growth NA
Small Value NA
Foreign Stock NA
Emerging Market NA
Precious Metals NA
Intermediate Bond NA
High Yield Bond NA
Foreign Bond NA
Style Analysis Horizontal Bar Chart
BIPSX : Risk Analysis
Beta v. S&P 500 1.61
Beta v. EAFE -0.05
Beta v. Barclays Agg Bond 3.05
Alpha 3 Yr 29.65
Alpha 5 Yr 11.71
R-Sq 3 Yr 0.39
R-Sq 5 Yr 0.33
Std Dev 3 Yr 27.56
Std Dev 5 Yr 27.33
Sharpe 3 Yr 2.08
Sharpe 5 Yr 1.44
BIPSX : Fees
Expense Ratio 2.55
% Max Load NA
% Min Load NA
% Deferred Load NA
% Redemption NA
% Max 12 B1 Fee 1.00
% Max Mgt Fee 0.75
BIPSX : Purchase Choices:
Min Initial Investment 15000
Min Subsequent Investment 0
BIPSX : Returns Analysis - Annual

Line chart

  2004200520062007200820092010201120122013YTD
NAV ($) 11.0813.9612.6011.8711.6211.8712.5013.4322.0541.4438.53
Total Return (%) 15.2325.99-9.70-5.77-2.122.155.307.4364.18114.22-0.16
Annual Dividend Yield (%) 0.000.000.000.000.000.000.000.000.000.000.00
Relative Performance
Rel Performance-S&P500(%) 43.64211.00-255.02-112.66348.82-242.70-97.5953.38481.87818.40-19.69
Rel Performance-Obj.Ret.(%) 64.57170.28-134.41-146.36215.71-197.26-27.20-3.11449.48679.14-69.84
Ret.Quintile vs Obj(1 is best) 11551543115
Turnover, Yields, and Gains
Fund Assets Net($mil) 5761511121425
Annual Turnover (%) 562.00510.00396.00373.00519.00762.00297.0037.002.0014.00
Annual Dividend Paid ($) 0.000.000.000.000.000.000.000.000.000.000.00
Annual Capital Gains Paid($) 0.000.000.000.000.000.000.000.000.001.380.00
BIPSX : Returns Analysis - Trailing Total Return
  1 Month 3 Month 6 Month YTD 1 Year 3 Year 5 Year 10 Year 15 Year 20 Year
Total Return (through 04/14) -13.93% -0.16% 14.89% -0.16% 56.03% 52.09% 34.63% 16.79% NA NA
Ret. Percentile vs. Obj. (1 is best) 99 99 57 99 1 1 1 1 NA NA
BIPSX : Stock Portfolio Snapshot - 04/14
Average Price/Earnings 42.58
Average Price/Book 6.04
Average EPS Growth 15.81
Average Market Value 67,873.00
BIPSX : Stock Sector Breakout - 04/14
Stock Sector Breakout
BIPSX : Top Holdings - 04/14
Name Weight Shares
GILEAD SCIENCES INC 13.26 919,092
AMGEN INC 9.62 452,328
ABBVIE INC 8.39 952,776
BIOGEN IDEC INC 7.89 141,152
VERTEX PHARMACEUTICALS INC 1.97 139,548
ALEXION PHARMACEUTICALS INC 3.32 117,092
REGENERON PHARMACEUTICALS 2.40 46,516
ILLUMINA INC 2.05 75,388
CELGENE CORP 6.71 247,016